Flawed Report Aims to Undercut Established Research on Abortion Pill Safety, Plus How a Federal Initiative to Study Autism May Overemphasize Environmental Toxins — The Monitor June 12, 2025 Page This volume highlights how a report criticized for flawed methodology is influencing renewed efforts to restrict access to mifepristone; a federal plan to study the causes of autism that could be contributing to stigma by over-emphasizing environmental toxins; and the resurgence of false claims about fetal tissue in vaccines.
U.S. Global Health Legislation Tracker June 3, 2025 Fact Sheet This tracker provides a listing of global health-related legislation introduced in the current Congress.
An Update on PEPFAR Reauthorization May 29, 2025 Blog This Policy Watch provides an update on the status of PEPFAR reauthorization, which expired on March 25, 2025, allowing certain provisions to lapse.
Major Federal and State Funding Cuts Facing Planned Parenthood May 15, 2025 Issue Brief This issue brief presents data from the most recent tracking poll asking if people have ever visited a Planned Parenthood clinic for health care services and looks at the funding cuts Planned Parenthood is currently facing including Medicaid, Title X, and Teen Pregnancy Prevention funds.
Reported Legal Abortions by Race of Women Who Obtained Abortion by the State of Occurrence May 1, 2025 State Indicator
Rate of Legal Abortions per 1,000 Women Aged 15-44 Years by State of Occurrence May 1, 2025 State Indicator
State and Federal Reproductive Rights and Abortion Litigation Tracker April 17, 2025 Report This State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.
